NPI: 1659718781 · ZILLAH, WA 98953 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/30/2013
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/30/2013 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,500 | $542K |
| 2019 | 10,688 | $513K |
| 2020 | 12,495 | $602K |
| 2021 | 14,407 | $627K |
| 2022 | 13,615 | $599K |
| 2023 | 8,249 | $444K |
| 2024 | 3,721 | $458K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 30,734 | 2,256 | $2.92M |
| A4657 | Syringe, with or without needle, each | 5,629 | 1,850 | $717K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,644 | 1,424 | $92K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 548 | 255 | $30K |
| J1756 | Injection, iron sucrose, 1 mg | 5,393 | 1,410 | $21K |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,226 | 961 | $6K |
| 90674 | 95 | 77 | $450.06 | |
| G0008 | Administration of influenza virus vaccine | 60 | 47 | $56.76 |
| 83970 | 189 | 132 | $0.00 | |
| 85041 | 329 | 239 | $0.00 | |
| 85048 | 329 | 239 | $0.00 | |
| 83540 | 160 | 117 | $0.00 | |
| 82728 | 158 | 116 | $0.00 | |
| 83550 | 160 | 117 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 21 | 14 | $0.00 |